Skipping of Exon 20 in EP300 : A Novel Variant Linked to Rubinstein–Taybi Syndrome With Atypical and Severe Clinical Manifestations
Clinical Genetics · 2025
DOI: 10.1111/cge.14654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Lisa Pavinato und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Oncology Research, BIOS+, Bellinzona, Switzerland. Hauptthemen laut MEDLINE: E1A-Associated p300 Protein, Exons, Rubinstein-Taybi Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry for Education, University and Research, MInistry of Health, European Union-NextGeneration EU.
Abstract (Originalsprache)
Rubinstein–Taybi syndrome (RSTS) is a rare autosomal dominant neurodevelopmental disorder linked to haploinsufficiency of CREBBP (RSTS1) and EP300 (RSTS2) genes. Characteristic features often include distinctive facial traits, broad thumbs and toes, short stature, and various degrees of intellectual disability. The clinical presentation of RSTS is notably variable, making it challenging to establish a clear genotype–phenotype correlation, except for specific variants which cause the allelic Menke–Hennekam syndrome. Trio exome analysis, data collection via networking and GeneMatcher platforms, transcript processing analysis, and DNA methylation profiling were performed. We identified two unrelated patients with de novo variants in EP300 (NM_001429.4: c.3671+5G>C; c.3671+5_3671+8delGTAA) predicted to cause in‐frame exon 20 skipping, confirmed in one patient. In silico 3D protein modeling suggested that exon 20 deletion (comprising 27 amino acids) likely alters the structural conformation between the RING_CBP‐p300 and HAT‐KAT11 domains. Clinically, both patients displayed severe RSTS2‐like clinical features, including autism spectrum disorder, speech delay, hearing loss, microcephaly, developmental delay, and intellectual disability, alongside ocular, respiratory, and cardiovascular abnormalities. Additionally, one patient developed early‐onset colorectal cancer. DNA methylation profiling in Subject #1 confirmed RSTS but did not align with the specific episignatures for RSTS1 or RSTS2. We propose that skipping of exon 20 in EP300 is associated with a distinct form of Rubinstein–Taybi syndrome featuring clinical characteristics not fully aligning with RSTS1 or RSTS2. Our findings increase the understanding of RSTS genetic and molecular basis and stress the need for further research to establish definitive genotype–phenotype correlations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Oncology Research, BIOS+, Bellinzona, Switzerland.
- Università Della Svizzera Italiana, Lugano, Switzerland.
- Department of Neurosciences Rita Levi-Montalcini, University of Turin, Turin, Italy.
- Medical Genetics Unit, Città Della Salute e Della Scienza University Hospital, Turin, Italy.
- Santa Croce e Carle Hospital, Pediatrics Unit, Cuneo, Italy.
- Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy.
ORCID-Profile: Lisa Pavinato, Silvia Carestiato, Slavica Trajkova, Giovanna Mantovani, Luisa De Sanctis, Jennifer Kerkhof, Simona Cardaropoli, Alessandro Bruselles, Silvia De Rubeis, Joseph D Buxbaum, Marco Tartaglia, Giovanni Battista Ferrero, Alfredo Brusco
Förderung
- Ministry for Education, University and Research
- MInistry of Health
- European Union-NextGeneration EU
- Ministero della Salute
Zitieren
APA
Pavinato, L., Carestiato, S., Trajkova, S., Sorasio, L., Mantovani, G., De Sanctis, L., Kerkhof, J., McConkey, H., Rzasa, J., Todd, E., Balzo, M., Cardaropoli, S., Bruselles, A., De Rubeis, S., Buxbaum, J. D., Tartaglia, M., Sadikovic, B., Ferrero, G. B., & Brusco, A. (2025). Skipping of Exon 20 in EP300 : A Novel Variant Linked to Rubinstein–Taybi Syndrome With Atypical and Severe Clinical Manifestations. Clinical Genetics. https://doi.org/10.1111/cge.14654
Vancouver
Pavinato L, Carestiato S, Trajkova S, Sorasio L, Mantovani G, De Sanctis L, et al. Skipping of Exon 20 in EP300 : A Novel Variant Linked to Rubinstein–Taybi Syndrome With Atypical and Severe Clinical Manifestations. Clinical Genetics. 2025. doi:10.1111/cge.14654
BibTeX
@article{Pavinato2025,
author = {Pavinato, Lisa and Carestiato, Silvia and Trajkova, Slavica and Sorasio, Lorena and Mantovani, Giovanna and De Sanctis, Luisa and Kerkhof, Jennifer and McConkey, Haley and Rzasa, Jessica and Todd, Emily and Balzo, Maria and Cardaropoli, Simona and Bruselles, Alessandro and De Rubeis, Silvia and Buxbaum, Joseph D and Tartaglia, Marco and Sadikovic, Bekim and Ferrero, Giovanni Battista and Brusco, Alfredo},
title = {Skipping of Exon 20 in EP300 : A Novel Variant Linked to Rubinstein–Taybi Syndrome With Atypical and Severe Clinical Manifestations},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14654}
}
EUVIMED